Anti-Malaria Drug From India Reaches US

51

Washington: Days after New Delhi lifted a ban on export of the anti-malarial drug, a consignment of hydroxychloroquine has arrived in the US from India.

Earlier this week, India at the request of President Donald Trump cleared the export of 35.82 lakh tablets of hydroxychloroquine to the US along with nine metric tons of active pharmaceutical ingredient

Trump, during a phone call last week, asked Prime Minister Narendra Modi to lift the hold on American order of the anti-malarial drug, of which India is the major producer. India, which manufactures 70 per cent of the world’s supply of hydroxychloroquine, lifted the ban on April 7.

Hydroxychloroquine has been identified by the US Food and Drug Administration as a possible treatment for the COVID-19 and it is being tested on more than 1,500 coronavirus patients in New York.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.